Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C02 ANTIHYPERTENSIVES
C02K OTHER ANTIHYPERTENSIVES
C02KX Antihypertensives for pulmonary arterial hypertension
C02KX05 Riociguat
D09572 Riociguat (JAN/USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Respiratory Tract/Pulmonary Agents
Pulmonary Antihypertensives
Guanylate Cyclase (sGC) stimulators
Riociguat
D09572 Riociguat (JAN/USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
219 Miscellaneous
2190 Miscellaneous
D09572 Riociguat (JAN/USAN/INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG03006 Guanylate cyclase activator
D09572 Riociguat
Metabolizing enzyme substrate
DG01891 CYP1A1 substrate
D09572 Riociguat
DG02918 CYP2C8 substrate
D09572 Riociguat
DG02954 CYP2J2 substrate
D09572 Riociguat
DG01633 CYP3A/CYP3A4 substrate
D09572 Riociguat
Transporter substrate
DG01665 ABCB1 substrate
D09572 Riociguat
DG01913 ABCG2 substrate
D09572 Riociguat
Target-based classification of drugs [BR:br08310]
Enzymes
Lyases (EC4)
Phosphorus-oxygen lyases
GUCY1A
D09572 Riociguat (JAN/USAN/INN) <JP/US>
GUCY1B
D09572 Riociguat (JAN/USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09572
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D09572
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D09572
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09572
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D09572
Drug transporters
D09572